February 2007





Expanding the Role of Peripheral Endografts

By John R. Laird, Jr, MD, Chief Medical Editor


A Word From an EVA-3S Participant

Alain Branchereau, MD, a Principal Investigator for the EVA-3S trial, discusses the protocol of the trial, its physician experience requirements, and the future of CAS.

By Alain Branchereau, MD

Raising Critical Questions

Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD, discusses the questions she posed to the EVA-3S and SPACE presenters at VEITH, the difference between failure to show noninferiority and superiority, and critical aspects of future trial design.

By Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD

Improving Trial Design

Mark H. Wholey, MD, explains why patient selection and operator experience remain critical to CAS studies and the future of the procedure.

By Mark H. Wholey, MD

A Word From an EVA-3S Participant

Alain Branchereau, MD, a Principal Investigator for the EVA-3S trial, discusses the protocol of the trial, its physician experience requirements, and the future of CAS.

By Alain Branchereau, MD

Healthy Discussion

Richard Green, MD, discusses how these trial data have caused the endovascular community to debate the safety of CAS and proper trial design–and how that is a good thing.

By Richard Green, MD

CAPTURE in the Context of Space and EVA-3S

William A. Gray, MD, discusses what lessons can be learned from large-population, high-enrollment, postapproval registries.

By William A. Gray, MD


Covered Stent Treatment of an SMA Aneurysm

Endovascular techniques can be the first line of therapy for visceral artery aneurysms.

By Michael Wholey, MD, and William Wu, MD


Percutaneous Sutureless Venous Anastomosis

A novel technique in the establishment of a venous graft anastomosis.

By Shahriar Moossavi, MD, PhD, and John R. Ross, MD


Endograft Treatment in the SFA

Current SFA stent graft technology has overcome early shortcomings and carries the potential to become the standard of care in selected patients.

By Mark W. Mewissen, MD

Endograft Treatment of Complex Aortoiliac Disease

Six case studies detailing the use of balloon-expandable PTFE-covered stent endografts in the iliac anatomy.

By Leonardo C. Clavijo, MD, PhD, and John R. Laird, Jr, MD

Using Covered Stents in the Carotid Arteries

An overview of the potential uses for covered stents in this anatomy, including a review of the literature and procedural considerations.

By David L. Dawson, MD

A 2007 Update on Treating Nitinol Stent Restenosis

Using Viabahn covered stents to treat restenosis in the superficial femoral artery.

By Gary M. Ansel, MD, FACC; Charles F. Botti, Jr, MD; Melinda Taylor, RN; and Mitchell J. Silver, DO

Hypogastric Artery Embolization and Endografting

Controversies and techniques on the prevention and treatment of endoleaks.

By Robert J. Rosen, MD, and Richard M. Green, MD

Treating Venous Outflow Stenosis and Pseudoaneurysm in Dialysis Access Grafts

A minimally invasive method using the Viabahn endograft to treat pseudoaneurysm and venous outflow stenosis: a 2-year follow-up study.

By Mouhamad O. Annous, MD, and Srilatha Kanumuru, MD

Plaque Excision and Stent Graft Deployment for SFA Occlusion

A case report on this combination therapy.

By John Paul Runyon, MD


Overview of Vascular Closure

The Endovascular Today annual review.

By Zoltan G. Turi, MD


Cleveland Clinic Stent Summit 2006

Discussions on clinical testing of AAA endovascular grafts.

By Robert G. Whirley, PhD; Matthew S. Waninger, PhD; and Roy K. Greenberg, MD

An Interview with Zvonimir Krajcer, MD

A leading interventional cardiologist discusses percutaneous AAA repair, the role of creativity in intervention, and features of the C3 Conference.

By Zvonimir Krajcer, MD

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.